Investment
Features
FeesSafety
Academy
More
Pluang+

Smooth Rock Ventures to rename as Catalyst One Exploration, trading as CATX from Sept 22, 2026

Company Fundamentals
18 Sep 2026
Newsfile Corp
View Source
Neutral
Smooth Rock Ventures to rename as Catalyst One Exploration, trading as CATX from Sept 22, 2026

Smooth Rock Ventures Corp. will change its name to Catalyst One Exploration Corp. effective after market close on September 21, 2026. The company's shares will trade under the new name and ticker symbol CATX on the TSX Venture Exchange starting September 22, 2026. This change does not affect share structure or shareholder rights, and no action is needed from shareholders. The company focuses on mineral exploration in Nevada, including its Palmetto Gold Project.

Smooth Rock Ventures name change to Catalyst One Exploration Corp. offers context for readers. For those tracking Basic Materials, 20 of 34 US stocks rose and 13 fell as of Sep 18, 2026 19:13 WIB. Notable moves include TECK at USD 66.08 (+1.32%), MT at USD 74.26 (-1.22%) with 100% buy orders, and KGC at USD 28.76 (+1.00%) with 99% buy orders.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
47 minutes ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
1 hour ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
2 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
3 hours ago
Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays cuts Lennar price target to $70 amid weak Q3 earnings and housing market challenges

Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...

Analyst Insights
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App